Veracyte, Inc. (VCYT) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Veracyte, Inc. · Health Care · ref. ETF XLV · 56 calls · price $43.11
What the company does: Veracyte, Inc. operates as a diagnostics company in the United States and internationally.
📈 Veracyte, Inc. (VCYT) stock price
$43.11+27.0% over range
Oct 14, 25low $30.01 · high $60.49Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
75% recommend buying · 8 analysts
📊 JPI status : Veracyte, Inc. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 VCYT price target & analyst consensus — price $43.11
The price target · all analysts combined (8 targets)
Highest target · 1 firm of 8$69+60.1%
Median target · of 8 targets$60+39.2%
Lowest target · 1 firm of 8$44+2.1%
Current price$43.11
Where these 8 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
8100%
$44 ↔ $69
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: UBS — 59% of its targets hit on this sector (76 calls tested). It aims for $65 (+51 %), call made on September 10, 2026, maturing on September 10, 2027 (34 d ago).
The 1 reliable analyst
$65+51 %
The 7 other firms
$55+28 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $65 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 8 ratings (last 6 months)
Strong Buy00%
Buy675%
Hold113%
Sell113%
Strong Sell00%
Go deeper on the analysts
🎯 VCYT price target all
All 56 calls, one by one, with our verdict on each firm.
→ See all 56 targets, analyst by analyst💡 The best analysts on VCYT most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in VCYT? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Veracyte, Inc.? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
🏛️ Which US Congress members hold Veracyte, Inc. (VCYT)?
2 Congress members have disclosed VCYT buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Gilbert Cisneros 3× · 48%Josh Gottheimer 2× · 56%
✅ Historical analyst reliability on VCYT
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Goldman Sachs ↗ | 100% | +49.8% | 4 |
| UBS ↗ | 100% | +15.5% | 4 |
| Scotiabank ↗ | 100% | +10.1% | 2 |
| Guggenheim ↗ | 100% | +4.0% | 3 |
| Needham ↗ | 62% | +16.3% | 21 |
| Leerink Swann | 50% | +42.0% | 2 |
| BTIG ↗ | 50% | -1.1% | 2 |
| Morgan Stanley ↗ | 46% | -3.5% | 13 |
| SVB Leerink | 40% | -14.4% | 10 |
| Stephens & Co. ↗ | 29% | -2.8% | 7 |
See the other 2 firms
| Truist Securities ↗ | 0% | -52.4% | 2 |
| Raymond James ↗ | 0% | -23.9% | 7 |
📊 What $1,000 invested in Veracyte, Inc. would be worth › open the full page
In short — $1,000 invested in Veracyte, Inc. 10 years ago would be worth $7,864 today, i.e. +23%/yr on average. Best year: 2019 (+122%), worst: 2022 (-42%). Price performance, excluding dividends.
If I'd invested $1,000 in Veracyte, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,430 | +43% |
| 3 years ago | $2,386 | +139% |
| 5 years ago | $1,157 | +16% |
Return by year (Veracyte, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +34% | $1,345 (+34%) |
| 2025 | +6% | $1,430 (+43%) |
| 2024 | +44% | $2,058 (+106%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Veracyte, Inc.
Loading news…
📋 All analyst calls on VCYT
Filtered on — · ✕ show all
Freedom Capital Markets
Sep 15, 26
▲ Buy · 🎯$66
Price at call : $40.14 — upside +64%
Today : $43.11 — upside +53%
🎯 on VCYT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Sep 15, 27
matures : Sep 15, 27
▲ Buy · 🎯$65
Price at call : $42.03 — upside +55%
Today : $43.11 — upside +51%
🎯 on VCYT : 100% (4 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Sep 9, 27
matures : Sep 9, 27
Piper Sandler ↗
Aug 4, 26
▲ Overweight · 🎯$54
Price at call : $46.15 — upside +17%
Today : $43.11 — upside +25%
🎯 on VCYT : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
Stephens & Co. ↗
Aug 4, 26
▲ Overweight · 🎯$55
Price at call : $46.41 — upside +19%
Today : $43.11 — upside +28%
🎯 on VCYT : 29% (7 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
Morgan Stanley ↗
Aug 4, 26
▼ Underweight · 🎯$44
Price at call : $46.41 — upside -5%
Today : $43.11 — upside +2%
🎯 on VCYT : 0% (1 call matured) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
Canaccord Genuity ↗
Aug 3, 26
■ Hold neutral · not a buy · 🎯$50
Price at call : $46.41 — gap to target +8%
Today : $43.11 — gap to target +16%
🎯 on VCYT : no call matured yet · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Aug 3, 27
matures : Aug 3, 27
▲ Buy · 🎯$69
Price at call : $46.32 — upside +49%
Today : $43.11 — upside +60%
🎯 on VCYT : 60% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
▲ Buy · 🎯$69
Price at call : $59.78 — upside +15%
Today : $43.11 — upside +60%
🎯 on VCYT : 60% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
See the other 48 calls, newest to oldest
Piper Sandler ↗
Jul 15, 26
▲ Overweight · 🎯$66
Price at call : $59.51 — upside +11%
Today : $43.11 — upside +53%
🎯 on VCYT : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Jul 15, 27
matures : Jul 15, 27
Canaccord Genuity ↗
Jul 14, 26
■ Hold neutral · not a buy · 🎯$60
Price at call : $56.62 — gap to target +6%
Today : $43.11 — gap to target +39%
🎯 on VCYT : no call matured yet · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
Morgan Stanley ↗
Jul 9, 26
▼ Underweight · 🎯$47
Price at call : $56.97 — upside -18%
Today : $43.11 — upside +9%
🎯 on VCYT : 0% (1 call matured) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
Guggenheim ↗
Jun 29, 26
▲ Buy · 🎯$65
Price at call : $58.73 — upside +11%
Today : $43.11 — upside +51%
🎯 on VCYT : 100% (3 calls matureds) · 📊 on Health : 64.7% · +17.5% (51 calls)
in progress (365j)
matures : Jun 29, 27
matures : Jun 29, 27
▲ Buy · 🎯$57
Price at call : $47.8 — upside +19%
Today : $43.11 — upside +32%
🎯 on VCYT : 60% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Jun 1, 27
matures : Jun 1, 27
▲ Buy · 🎯$48
Price at call : $47.99 — upside +0%
Today : $43.11 — upside +11%
🎯 on VCYT : 60% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
Canaccord Genuity ↗
May 7, 26
■ Hold neutral · not a buy · 🎯$42
Price at call : $40.76 — gap to target +3%
Today : $43.11 — gap to target -3%
🎯 on VCYT : no call matured yet · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
▲ Buy · 🎯$52
Price at call : $40.76 — upside +28%
Today : $43.11 — upside +21%
🎯 on VCYT : 100% (4 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
Canaccord Genuity ↗
Apr 20, 26
■ Hold neutral · not a buy · 🎯$40
Price at call : $33.51 — gap to target +19%
Today : $43.11 — gap to target -7%
🎯 on VCYT : no call matured yet · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Apr 20, 27
matures : Apr 20, 27
▲ Buy · 🎯$45
Price at call : $32.44 — upside +39%
Today : $43.11 — upside +4%
🎯 on VCYT : no call matured yet · 📊 on Health : 49.6% · +9.4% (137 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
▲ Buy · 🎯$48
Price at call : $32.4 — upside +48%
Today : $43.11 — upside +11%
🎯 on VCYT : 60% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Apr 1, 27
matures : Apr 1, 27
Guggenheim ↗
Mar 30, 26
▲ Buy · 🎯$45
Price at call : $32.21 — upside +40%
Today : $43.11 — upside +4%
🎯 on VCYT : 100% (3 calls matureds) · 📊 on Health : 64.7% · +17.5% (51 calls)
in progress (365j)
matures : Mar 30, 27
matures : Mar 30, 27
Morgan Stanley ↗
Mar 6, 26
▼ Underweight · 🎯$37
Price at call : $33.37 — upside +11%
Today : $43.11 — upside -14%
🎯 on VCYT : 0% (1 call matured) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Mar 6, 27
matures : Mar 6, 27
▲ Buy · 🎯$48
Price at call : $38.75 — upside +24%
Today : $43.11 — upside +11%
🎯 on VCYT : 60% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
Guggenheim ↗
Jan 5, 26
▲ Buy · 🎯$50
Price at call : $45.64 — upside +10%
Today : $43.11 — upside +16%
🎯 on VCYT : 100% (3 calls matureds) · 📊 on Health : 64.7% · +17.5% (51 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
Morgan Stanley ↗
Dec 2, 25
▼ Underweight · 🎯$48
Price at call : $47.75 — upside +1%
Today : $43.11 — upside +11%
🎯 on VCYT : 0% (1 call matured) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
Morgan Stanley ↗
Nov 11, 25
▼ Underweight · 🎯$40
Price at call : $42.3 — upside -5%
Today : $43.11 — upside -7%
🎯 on VCYT : 0% (1 call matured) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Nov 11, 26
matures : Nov 11, 26
▲ Buy · 🎯$48
Price at call : $41.69 — upside +15%
Today : $43.11 — upside +11%
🎯 on VCYT : 100% (4 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
Canaccord Genuity ↗
Nov 5, 25
■ Hold neutral · not a buy · 🎯$43
Price at call : $41.69 — gap to target +3%
Today : $43.11 — gap to target -0%
🎯 on VCYT : no call matured yet · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
Guggenheim ↗
Nov 5, 25
▲ Buy · 🎯$45
Price at call : $41.69 — upside +8%
Today : $43.11 — upside +4%
🎯 on VCYT : 100% (3 calls matureds) · 📊 on Health : 64.7% · +17.5% (51 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
▲ Buy · 🎯$44
Price at call : $46.04 — upside -4%
Today : $43.11 — upside +2%
🎯 on VCYT : 60% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
Canaccord Genuity ↗
Oct 20, 25
■ Hold neutral · not a buy · 🎯$40
Price at call : $36.65 — gap to target +9%
Today : $43.11 — gap to target -7%
🎯 on VCYT : no call matured yet · 📊 on Health : 39.9% · -0.9% (148 calls)
in progress (365j)
matures : Oct 20, 26
matures : Oct 20, 26
Freedom Capital Markets
Oct 17, 25
▲ Buy · 🎯$45
Price at call : $35.83 — upside +26%
Today : $43.11 — upside +4%
🎯 on VCYT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Oct 17, 26
matures : Oct 17, 26
▲ Buy · 🎯$42
Price at call : $29.71 — upside +41%
Today : $43.11 — upside -3%
Expected +41% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on VCYT : 100% (4 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
+33.6%
stock +34% · XLV +8%
matured May 8, 26
▲ Buy · 🎯$41
Price at call : $31.21 — upside +31%
Today : $43.11 — upside -5%
Expected +31% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on VCYT : 60% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+29.5%
stock +30% · XLV +7%
matured May 8, 26
Guggenheim ↗
Apr 9, 25
▲ Buy · 🎯$37
Price at call : $30.25 — upside +22%
Today : $43.11 — upside -14%
Expected +22% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 100% (3 calls matureds) · 📊 on Health : 64.7% · +17.5% (51 calls)
+2.8%
stock +3% · XLV +9%
matured Apr 9, 26
Stephens & Co. ↗
Mar 26, 25
▲ Overweight · 🎯$45
Price at call : $31.1 — upside +45%
Today : $43.11 — upside +4%
Expected +45% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 29% (7 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
-3.5%
stock -4% · XLV -1%
matured Mar 26, 26
Craig-Hallum ↗
Mar 20, 25
▲ Buy · 🎯$45
Price at call : $31.82 — upside +41%
Today : $43.11 — upside +4%
Expected +41% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 100% (1 call matured) · 📊 on Health : 52% · +14.5% (25 calls)
+5.4%
stock +5% · XLV -1%
matured Mar 20, 26
▲ Buy · 🎯$49
Price at call : $35.53 — upside +38%
Today : $43.11 — upside +14%
Expected +38% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 100% (4 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
+9.1%
stock +9% · XLV +6%
matured Feb 25, 26
Guggenheim ↗
Feb 25, 25
▲ Buy · 🎯$45
Price at call : $35.53 — upside +27%
Today : $43.11 — upside +4%
Expected +27% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 100% (3 calls matureds) · 📊 on Health : 64.7% · +17.5% (51 calls)
+9.1%
stock +9% · XLV +6%
matured Feb 25, 26
▲ Buy · 🎯$51
Price at call : $33.46 — upside +52%
Today : $43.11 — upside +18%
Expected +52% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 60% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+6.8%
stock +7% · XLV +6%
matured Feb 25, 26
▲ Buy · 🎯$51
Price at call : $44.44 — upside +15%
Today : $43.11 — upside +18%
Expected +15% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 60% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-12.8%
stock -13% · XLV +6%
matured Jan 29, 26
Goldman Sachs ↗
Dec 5, 24
■ Neutral neutral · not a buy · 🎯$37
Price at call : $42.84 — gap to target -14%
Today : $43.11 — gap to target -14%
🎯 on VCYT : 100% (1 call matured) · 📊 on Health : 51.9% · +5.8% (104 calls)
in progress (365j)
matures : Dec 5, 25
matures : Dec 5, 25
Morgan Stanley ↗
Nov 18, 24
▼ Underweight · 🎯$28
Price at call : $39.15 — upside -28%
Today : $43.11 — upside -35%
Expected -28% · Actual +2% · Reason (≤ −15%) : ✗ No
🎯 on VCYT : 0% (1 call matured) · 📊 on Health : 55.5% · +4.6% (182 calls)
-2.0%
stock +2% · XLV +8%
matured Nov 18, 25
Scotiabank ↗
Nov 8, 24
▲ Sector Outperform · 🎯$44
Price at call : $38.89 — upside +13%
Today : $43.11 — upside +2%
Expected +13% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 100% (1 call matured) · 📊 on Health : 80% · +13.8% (5 calls)
+8.9%
stock +9% · XLV -1%
matured Nov 8, 25
Goldman Sachs ↗
Nov 7, 24
▲ Buy · 🎯$38
Price at call : $36.48 — upside +4%
Today : $43.11 — upside -12%
Expected +4% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on VCYT : 100% (1 call matured) · 📊 on Health : 51.9% · +5.8% (104 calls)
+16.1%
stock +16% · XLV -2%
matured Nov 7, 25
▲ Buy · 🎯$46
Price at call : $36.48 — upside +26%
Today : $43.11 — upside +7%
Expected +26% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on VCYT : 100% (4 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
+16.1%
stock +16% · XLV -2%
matured Nov 7, 25
▲ Buy · 🎯$44
Price at call : $37.34 — upside +18%
Today : $43.11 — upside +2%
Expected +18% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 60% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
+11.7%
stock +12% · XLV -2%
matured Nov 7, 25
Leerink Partners ↗
Oct 17, 24
▲ Outperform · 🎯$40
Price at call : $34.44 — upside +16%
Today : $43.11 — upside -7%
Expected +16% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 100% (1 call matured) · 📊 on Health : 54.5% · +7.0% (11 calls)
+6.4%
stock +6% · XLV -5%
matured Oct 17, 25
▲ Buy · 🎯$43
Price at call : $34.72 — upside +24%
Today : $43.11 — upside -0%
Expected +24% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 100% (4 calls matureds) · 📊 on Health : 48.7% · +2.2% (76 calls)
+3.1%
stock +3% · XLV -7%
matured Oct 16, 25
Guggenheim ↗
Oct 10, 24
▲ Buy · 🎯$40
Price at call : $34.02 — upside +18%
Today : $43.11 — upside -7%
Expected +18% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 100% (3 calls matureds) · 📊 on Health : 64.7% · +17.5% (51 calls)
+0.2%
stock +0% · XLV -8%
matured Oct 10, 25
▲ Buy · 🎯$37
Price at call : $31.62 — upside +17%
Today : $43.11 — upside -14%
Expected +17% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 60% (5 calls matureds) · 📊 on Health : 39.2% · -2.7% (400 calls)
-5.3%
stock -5% · XLV -12%
matured Aug 28, 25
Stephens & Co. ↗
Oct 10, 23
▲ Overweight · 🎯$34
Price at call : $22.32 — upside +52%
Today : $43.11 — upside -21%
Expected +52% · Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on VCYT : 29% (7 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
+44.6%
stock +45% · XLV +17%
matured Oct 9, 24
Stephens & Co. ↗
May 8, 23
▲ Overweight · 🎯$30
Price at call : $22.63 — upside +33%
Today : $43.11 — upside -30%
Expected +33% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 29% (7 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
-7.1%
stock -7% · XLV +7%
matured May 7, 24
Stephens & Co. ↗
May 5, 22
▲ Overweight · 🎯$30
Price at call : $18.44 — upside +63%
Today : $43.11 — upside -30%
Expected +63% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on VCYT : 29% (7 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
+22.7%
stock +23% · XLV +3%
matured May 5, 23
Stephens & Co. ↗
Mar 2, 22
▲ Overweight · 🎯$44
Price at call : $27.84 — upside +58%
Today : $43.11 — upside +2%
Expected +58% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 29% (7 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
-13.4%
stock -13% · XLV -3%
matured Mar 2, 23
Stephens & Co. ↗
Jan 7, 22
▲ Overweight · 🎯$52
Price at call : $33.58 — upside +55%
Today : $43.11 — upside +21%
Expected +55% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 29% (7 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
-31.3%
stock -31% · XLV -1%
matured Jan 7, 23
Stephens & Co. ↗
Oct 7, 14
▲ Overweight · 🎯$14
Price at call : $9.16 — upside +53%
Today : $43.11 — upside -68%
Expected +53% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on VCYT : 29% (7 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
-31.2%
stock -31% · XLV +8%
matured Oct 7, 15
Frequently asked questions
Should I buy Veracyte, Inc. stock?
This isn't buy advice. For Veracyte, Inc., the analyst consensus is "Buy", with an average price target of $60.00 (+39% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (4 calls tracked on Veracyte, Inc.). We show the numbers — you decide.
Is it too late to buy Veracyte, Inc.? How high can it go?
The most bullish analyst target on Veracyte, Inc. is $69.00 (+60% above today's price); the average is $60.00. That's the upside they see. Check how reliable those analysts have actually been on Veracyte, Inc. on our site before trusting it.
Is Veracyte, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 12 analysts have a real record on Veracyte, Inc., the best hitting 100% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Veracyte, Inc.? The case for and against
The arguments for and against, one by one, from the numbers: why invest in VCYT (and why hesitate).
What has Veracyte, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: VCYT performance & returns.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX